首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 78 毫秒
1.
2.
Recent advances in the characterization of the archaeal DNA replication system together with comparative genomic analysis have led to the identification of several previously uncharacterized archaeal proteins involved in replication and currently reveal a nearly complete correspondence between the components of the archaeal and eukaryotic replication machineries. It can be inferred that the archaeal ancestor of eukaryotes and even the last common ancestor of all extant archaea possessed replication machineries that were comparable in complexity to the eukaryotic replication system. The eukaryotic replication system encompasses multiple paralogs of ancestral components such that heteromeric complexes in eukaryotes replace archaeal homomeric complexes, apparently along with subfunctionalization of the eukaryotic complex subunits. In the archaea, parallel, lineage-specific duplications of many genes encoding replication machinery components are detectable as well; most of these archaeal paralogs remain to be functionally characterized. The archaeal replication system shows remarkable plasticity whereby even some essential components such as DNA polymerase and single-stranded DNA-binding protein are displaced by unrelated proteins with analogous activities in some lineages.Double-stranded DNA is the molecule that carries genetic information in all cellular life-forms; thus, replication of this genetic material is a fundamental physiological process that requires high accuracy and efficiency (Kornberg and Baker 2005). The general mechanism and principles of DNA replication are common in all three domains of life—archaea, bacteria, and eukaryotes—and include recognition of defined origins, melting DNA with the aid of dedicated helicases, RNA priming by the dedicated primase, recruitment of DNA polymerases and processivity factors, replication fork formation, and simultaneous replication of leading and lagging strands, the latter via Okazaki fragments (Kornberg and Baker 2005; Barry and Bell 2006; Hamdan and Richardson 2009; Hamdan and van Oijen 2010). Thus, it was a major surprise when it became clear that the protein machineries responsible for this complex process are drastically different, especially in bacteria compared with archaea and eukarya. The core components of the bacterial replication systems, such as DNA polymerase, primase, and replication helicase, are unrelated or only distantly related to their counterparts in the archaeal/eukaryotic replication apparatus (Edgell 1997; Leipe et al. 1999).The existence of two distinct molecular machines for genome replication has raised obvious questions on the nature of the replication system in the last universal common ancestor (LUCA) of all extant cellular life-forms, and three groups of hypotheses have been proposed (Leipe et al. 1999; Forterre 2002; Koonin 2005, 2006, 2009; Glansdorff 2008; McGeoch and Bell 2008): (1) The replication systems in Bacteria and in the archaeo–eukaryotic lineage originated independently from an RNA-genome LUCA or from a noncellular ancestral state that encompassed a mix of genetic elements with diverse replication strategies and molecular machineries. (2) The LUCA was a typical cellular life-form that possessed either the archaeal or the bacterial replication apparatus in which several key components have been replaced in the other major cellular lineage. (3) The LUCA was a complex cellular life-form that possessed both replication systems, so that the differentiation of the bacterial and the archaeo–eukaryotic replication machineries occurred as a result of genome streamlining in both lines of descent that was accompanied by differential loss of components. With regard to the possible substitution of replication systems, a plausible mechanism could be replicon takeover (Forterre 2006; McGeoch and Bell 2008). Under the replicon takeover hypothesis, mobile elements introduce into cells a new replication system or its components, which can displace the original replication system through one or several instances of integration of the given element into the host genome accompanied by inactivation of the host replication genes and/or origins of replication. This scenario is compatible with the experimental results showing that DNA replication DNA in Escherichia coli with an inactivated DnaAgene or origin of replication can be rescued by the replication apparatus of R1 or F1 plasmids integrated into the bacterial chromosome (Bernander et al. 1991; Koppes 1992). Furthermore, genome analysis suggests frequent replicon fusion in archaea and bacteria (McGeoch and Bell 2008); in particular, such events are implied by the observation that in archaeal genomes, genes encoding multiple paralogs of the replication helicase MCM and origins of replication are associated with mobile elements (Robinson and Bell 2007; Krupovic et al. 2010). Replicon fusion also is a plausible path from a single origin of replication that is typical of bacteria to multiple origins present in archaea and eukaryotes. However, all the evidence in support of frequent replicon fusion and the plausibility of replicon takeover notwithstanding, there is no evidence of displacement of the bacterial replication apparatus with the archaeal version introduced by mobile elements, or vice versa, displacement of the archaeal machinery with the bacterial version, despite the rapid accumulation of diverse bacterial and archaeal genome sequences. Thus, the displacement scenarios of DNA replication machinery evolution are so far not supported by comparative genomic data.Regardless of the nature of the DNA replication system (if any) in the LUCA and the underlying causes of the archaeo–bacterial dichotomy of replication machineries, the similarity between the archaeal and eukaryotic replication systems is striking (Leipe et al. 1999; Bell and Dutta 2002; Bohlke et al. 2002; Kelman and White 2005; Barry and Bell 2006). Thus, the archaeal replication system appears to be an ancestral version of the eukaryotic system and hence a good model for functional and structural studies aimed at gaining mechanistic insights into eukaryotic replication.

Table 1.

The relationship between archaeal and eukaryotic replication systems
Archaea (projection for LACA)Eukaryotes (projection for LECA)Comments
ORC complex
arORC1Orc1, Cdc6In LACA the ORC/Cdc6 complex probably consisted of two distinct subunits, and in LECA of six distinct. Both complexes might possess additional Orc6 and Cdt1 components.
arORC2Orc2, Orc3, Orc4, Orc5
TFIIB or homologaOrc6
WhiP or other wHTH proteinaCdt1
CMG complex
Archaeal Cdc45/RecJCdc45In many archaea and eukaryotes, CDC45/RecJ apparently contain inactive DHH phosphoesterase domains.
The RecJ family is triplicated in euryarchaea, and some of the paralogs could be involved in repair.
MCM is independently duplicated in several lineages of euryarchaea.
McmMcm2, Mcm3, Mcm4, Mcm5, Mcm6, Mcm7
Gins23Gins2, Gins3
Gins15Gins1, Gins5
Inactivated MCM homologaMcm10
CMG activation factors
RecQ/Sld2There is no evidence that kinases and phosphatases in archaea are directly involved in replication, although they probably regulate cell division.
Treslin/Sld3
TopBP1/Dpb11
STKCDK, DDK
PP2CPP2C
Primases
Prim1/p48PriSIn eukaryotes, Pol α is involved in priming by adding short DNA fragments to RNA primers.
In archaea, DnaG might be involved in priming specifically on the lagging strand.
Prim2a/p58PriL
DnaG
Polymerases
PolB3Pol α, Pol δ, Pol ζNo eukaryotic homologs of DP2 are known, but Zn fingers of Pol ε are apparently derived from DP2.
PolB1Pol ε
DP1B subunits of Pol α, Pol δ, Pol ζ, Pol ε
DP2
DNA polymerase sliding clamp and clamp loader
RFCLRFC1Eukaryotes have additional duplications of both RFCs and PCNA involved in checkpoint complexes (Rad27 and Rad1, Rad9, Hus1, respectively).
RFCSRFC2, RFC3, RFC4, RFC4
PCNAPCNA
Primer removal and gap closure
RNase H2RNase IIThere is a triplication of ligases (LigI, LigIII, LigIV) in eukaryotes, but only LigI is directly involved in replication.
In a few Halobacteria, ATP-dependent ligase is replaced by NAD-dependent ligase.
Fen1Fen1/EXO1, Rad2, Rad27
Lig1Lig1
SSB
arRPA1_longRpa1In Thermoproteales, RPA is displaced by the non-homologous ThermoSSB; two short RPA forms in many euryarchaea; expansion of short RPA forms in Halobacteria.
arRPA1_short and RPA2Rpa2
arCOG05741aRpa3
Open in a separate windowFor eukaryotic genes in Homo sapiens and Saccharomyces cerevisiae, gene names are indicated. Archaeal genes are denoted as in Barry and Bell (2006) or as introduced here.aNot confidently traced to LACA.In the last few years, there has been substantial progress in the study of the archaeal replication systems that has led to an apparently complete delineation of all proteins that are essential for replication (Berquist et al. 2007; Beattie and Bell 2011a; MacNeill 2011). The combination of experimental, structural, and bioinformatics studies has led to the discovery of archaeal homologs (orthologs) for several components of the replication system that have been previously deemed specific for eukaryotes (Barry and Bell 2006; MacNeill 2010, 2011; Makarova et al. 2012). Furthermore, complex evolutionary events that involve multiple lineage-specific duplications, domain rearrangements, and gene loss, and in part seem to parallel the evolution of the evolution of the replication system in eukaryotes, have been delineated for a variety of replication proteins in several archaeal lineages (Tahirov et al. 2009; Chia et al. 2010; Krupovic et al. 2010). Here we summarize these findings and present several additional case studies that show the complexity of evolutionary scenarios for the components of the archaeal replication machinery and new aspects of their relationship with the eukaryotic replication system.  相似文献   

3.
4.
5.
Dynamic changes in cytosolic and nuclear Ca2+ concentration are reported to play a critical regulatory role in different aspects of skeletal muscle development and differentiation. Here we review our current knowledge of the spatial dynamics of Ca2+ signals generated during muscle development in mouse, rat, and Xenopus myocytes in culture, in the exposed myotome of dissected Xenopus embryos, and in intact normally developing zebrafish. It is becoming clear that subcellular domains, either membrane-bound or otherwise, may have their own Ca2+ signaling signatures. Thus, to understand the roles played by myogenic Ca2+ signaling, we must consider: (1) the triggers and targets within these signaling domains; (2) interdomain signaling, and (3) how these Ca2+ signals integrate with other signaling networks involved in myogenesis. Imaging techniques that are currently available to provide direct visualization of these Ca2+ signals are also described.The recognition of Ca2+ as a key regulator of muscle contraction dates back to Sydney Ringer''s seminal observations in the latter part of the 19th Century (Ringer 1883; Ringer 1886; Ringer and Buxton 1887; see reviews by Martonosi 2000; Szent-Györgyi 2004). More recently, evidence is steadily accumulating to support the proposition that Ca2+ also plays a necessary and essential role in regulating embryonic muscle development and differentiation (Flucher and Andrews 1993; Ferrari et al. 1996; Lorenzon et al. 1997; Ferrari and Spitzer 1998, 1999; Wu et al. 2000; Powell et al. 2001; Jaimovich and Carrasco 2002; Li et al. 2004; Brennan et al. 2005; Harris et al. 2005; Campbell et al. 2006; Terry et al. 2006; Fujita et al. 2007; and see reviews by Berchtold et al. 2000; Ferrari et al. 2006; Al-Shanti and Stewart 2009). What is currently lacking, however, is extensive direct visualization of the spatial dynamics of the Ca2+ signals generated by developing and differentiating muscle cells. This is especially so concerning in situ studies. The object of this article, therefore, is to review and report the current state of our understanding concerning the spatial nature of Ca2+ signaling during embryonic muscle development, especially from an in vivo perspective, and to suggest possible directions for future research. The focus of our article is embryonic skeletal muscle development because of this being an area of significant current interest. Several of the basic observations reported, however, may also be common to cardiac muscle development and in some cases to smooth muscle development. What the recent development of reliable imaging techniques has most certainly done, is to add an extra dimension of complexity to understanding the roles played by Ca2+ signaling in skeletal muscle development. For example, it is clear that membrane-bound subcellular compartments, such as the nucleus (Jaimovich and Carrasco 2002), may have endogenous Ca2+ signaling activities, as do specific cytoplasmic domains, such as the subsarcolemmal space (Campbell et al. 2006). How these Ca2+ signals interact with specific down-stream targets within their particular domain, and how they might serve to communicate information among domains, will most certainly be one of the future challenges in elucidating the Ca2+-mediated regulation of muscle development.Any methodology used to study the properties of biological molecules and how they interact during development should ideally provide spatial information, because researchers increasingly need to integrate data about the interactions that underlie a biological process (such as differentiation) with information regarding the precise location within cells or an embryo where these interactions take place. Current Ca2+ imaging techniques are beginning to provide us with this spatial information, and are thus opening up exciting new avenues of investigation in our quest to understand the signaling pathways that regulate muscle development (
AnimalIntact animals/Cells in cultureCa2+ reporterReporter Loading ProtocolReference
Rat1° cultures prepared from hind limb muscle of neonatal rat pupsFluo 3-AMCells incubated in 5.4 µM reporter for 30 min at 25°C.Jaimovich et al. 2000
MouseMyotubes grown from C2C12 subclone of the C2 mouse muscle cell lineFluo 3-AMIncubated in 5 µM reporter plus 0.1% pluronic F-127 for 1 h at r.t.Flucher and Andrews 1993
Myotubes isolated from the intercostal muscles of E18 wild-type and RyR type 3-null mice.Fluo 3-AMCells incubated with 4 µM for 30 min at r.t.Conklin et al. 1999b
Myotubes in culture prepared from newborn mice.Fluo 3-AMCells incubated in 10 µM for 20 min.Shirokova et al. 1999
1° cultures prepared from hind limb muscle from newborn mice.Fluo 3-AMCells incubated in 5.4 µM reporter for 30 min at 25°C.Powell et al. 2001
Embryonic day 18 (E18) isolated diaphragm muscle fibersFluo 4-AMIncubated in 10 µM reporter for 30 min.Chun et al. 2003
ChickMyotubes prepared from leg or breast of 11-day chick embryosFluo 3-AMIncubated in 5 µM reporter plus 0.1% pluronic F-127 for 1 h at r.t.Flucher and Andrews 1993
Myoblasts isolated from thigh muscle of E12 embryos.Fluo 3-AM1 mM stock was diluted 1:200 with 0.2% pluronic F-127. Cells were incubated for 60 min at r.t. in the dark.Tabata et al. 2006
XenopusExposed myotome in dissected embryoFluo-3 AMIncubated dissected tissue in 10 µM reporter for 30–60 min.Ferrari and Spitzer 1999
1° myocyte cultures prepared from stage 15 Xenopus embryos.Fluo-4 AMCells incubated in 2 µM reporter plus 0.01% pluronic F-127 for 60 min.Campbell et al. 2006
ZebrafishIntact animalsCalcium green-1 dextran (10S)Reporter at 20 mM was injected into a single blastomere between the 32- and 128-cell stage.Zimprich et al. 1998
Intact animalsOregon Green 488 BAPTA dextranSingle blastomeres from 32-cell stage embryos injected with reporter (i.c. 100 µM) and tetramethylrhodamine dextran (i.c. 40 µM).Ashworth et al. 2001
Intact animalsOregon Green 488 BAPTA dextranMicroinjected with rhodamine dextran to give an intracellular concentration of ∼40 µM.Ashworth 2004
Intact animalsAequorinaEmbryos injected with 700 pg aeq-mRNA at the 1-cell stage and then incubated with 50 µM f-coelenterazine from the 64-cell stage.Cheung et al. 2006
Intact animalsAequorinTransgenic fish that express apoaequorin in the skeletal muscles were incubated with 50 µM f-coelenterazine from the 8-cell stage.Cheung et al. 2010
Open in a separate windowaExpression of aequorin was ubiquitous but it was suggested that the Ca2+ signals visualized in the trunk at the approximately 8–20-somite stage and at ∼47 hpf might play a role in muscle development.  相似文献   

6.
Mismatch Repair during Homologous and Homeologous Recombination     
Maria Spies  Richard Fishel 《Cold Spring Harbor perspectives in biology》2015,7(3)
  相似文献   

7.
Noncanonical Sites of Adult Neurogenesis in the Mammalian Brain     
David M. Feliciano  Angélique Bordey  Luca Bonfanti 《Cold Spring Harbor perspectives in biology》2015,7(10)
Two decades after the discovery that neural stem cells (NSCs) populate some regions of the mammalian central nervous system (CNS), deep knowledge has been accumulated on their capacity to generate new neurons in the adult brain. This constitutive adult neurogenesis occurs throughout life primarily within remnants of the embryonic germinal layers known as “neurogenic sites.” Nevertheless, some processes of neurogliogenesis also occur in the CNS parenchyma commonly considered as “nonneurogenic.” This “noncanonical” cell genesis has been the object of many claims, some of which turned out to be not true. Indeed, it is often an “incomplete” process as to its final outcome, heterogeneous by several measures, including regional location, progenitor identity, and fate of the progeny. These aspects also strictly depend on the animal species, suggesting that persistent neurogenic processes have uniquely adapted to the brain anatomy of different mammals. Whereas some examples of noncanonical neurogenesis are strictly parenchymal, others also show stem cell niche-like features and a strong link with the ventricular cavities. This work will review results obtained in a research field that expanded from classic neurogenesis studies involving a variety of areas of the CNS outside of the subventricular zone (SVZ) and subgranular zone (SGZ). It will be highlighted how knowledge concerning noncanonical neurogenic areas is still incomplete owing to its regional and species-specific heterogeneity, and to objective difficulties still hampering its full identification and characterization.The central nervous system (CNS) of adult mammals is assembled during developmental neurogenesis, and its architectural specificity is maintained through a vast cohort of membrane-bound and extracellular matrix molecules (Gumbiner 1996; Bonfanti 2006). Although CNS structure is sculpted by experience-dependent synaptic plasticity at different postnatal developmental stages (critical periods) (see Sale et al. 2009) and, to a lesser extent, during adulthood (Holtmaat and Svoboda 2009), the neural networks are rather stabilized in the “mature” nervous tissue (Spolidoro et al. 2009). The differentiated cellular elements forming adult neural circuitries remain substantially unchanged in terms of their number and types, because cell renewal/addition in the CNS is very low. This situation is intuitive because connectional, neurochemical, and functional specificities are fundamental features of the mature CNS in highly complex brains, allowing specific cell types to be connected and to act in a relatively invariant way (Frotscher 1992).Since the discovery of neural stem cells (NSCs) (Reynolds and Weiss 1992), we realized that the aforementioned rules of CNS stability have a main exception in two brain regions: the forebrain subventricular zone (SVZ) (Lois and Alvarez-Buylla 1994) and the hippocampal subgranular zone (SGZ) (Gage 2000). These “adult neurogenic sites” are remnants of the embryonic germinal layers (although indirectly for the SGZ, which forms ectopically from the embryonic germinative matrix), which retain stem/progenitor cells within a special microenvironment, a “niche,” allowing and regulating NSC activity (Kriegstein and Alvarez-Buylla 2009). In addition, the areas of destination (olfactory bulb and dentate gyrus) reached by neuroblasts generated within these neurogenic sites harbor specific, not fully identified yet, environmental signals allowing the integration of young, newborn neurons. These two “canonical” sites of adult neurogenesis have been found in all animal species studied so far, including humans (reviewed in Lindsey and Tropepe 2006; Bonfanti and Ponti 2008; Kempermann 2012; Grandel and Brand 2013). Although in several classes of vertebrates including fish, amphibians, and reptiles, adult neurogenesis is widespread in many areas of the CNS (Zupanc 2006; Chapouton et al. 2007; Grandel and Brand 2013), in mammals, the vast majority of the brain and spinal cord regions out of the germinal-layer-derived neurogenic sites are commonly referred to as “nonneurogenic parenchyma” (Sohur et al. 2006; Bonfanti and Peretto 2011; Bonfanti and Nacher 2012). However, this viewpoint has changed during the last few years. New examples of cell genesis, involving both neurogenesis and gliogenesis, have been shown to occur in the so-called nonneurogenic regions of the mammalian CNS (Horner et al. 2000; Dayer et al. 2005; Kokoeva et al. 2005; Luzzati et al. 2006; Ponti et al. 2008; reviewed in Butt et al. 2005; Nishiyama et al. 2009; Migaud et al. 2010; Bonfanti and Peretto 2011), suggesting that structural plasticity involving de novo neural cell genesis could be more widespread than previously thought. Apart from their temporal persistence (some of them represent examples of delayed developmental neurogenesis, which persist postnatally; see below), neurogliogenic processes vary as to their regional localization, origin, and final outcome. In this review, “noncanonical” neurogenic processes occurring in adult mammals will be reviewed by underlining their heterogeneity across the species and their differences in intensity and outcome with respect to canonical neurogenic sites.

Table 1.

Main sites of noncanonical neurogenesis in the mammalian brain
RatsMiceRabbitsMonkeys
NeocortexGould et al. 2001
Dayer et al. 2005a
Tamura et al. 2007
Shapiro et al. 2009Gould et al. 1999, 2001
Bernier et al. 2002
Nakatomi et al. 2002a
Pencea et al. 2001
Ohira et al. 2010a
Magavi et al. 2000a
Chen et al. 2004a
Vessal and Darian-Smith 2010a
Corpus callosumPencea et al. 2001
Piriform cortexbPekcec et al. 2006Shapiro et al. 2007Bernier et al. 2002
Olfactory tubercleShapiro et al. 2009Bedard et al. 2002b
StriatumDayer et al. 2005aShapiro et al. 2009Luzzati et al. 2006aBedard et al. 2002a;
2006a
Arvidsson et al. 2002a
Pencea et al. 2001
Liu et al. 2009a
Goldowitz and Hamre 1998a
Cho et al. 2007a
SeptumPencea et al. 2001
AmygdalaShapiro et al. 2009Luzzati et al. 2006aBernier et al. 2002
Hippocampus (Ammon’s horn)Rietze et al. 2000
Nakatomi et al. 2002a
ThalamusPencea et al. 2001
HypothalamusXu et al. 2005Kokoeva et al. 2007
Xu et al. 2005a
Pencea et al. 2001
Matsuzaki et al. 2009
Perez-Martin et al. 2010
Kokoeva et al. 2005a
Pierce and Xu 2010
Substantia nigraZhao et al. 2003
Zhao and Janson Lang 2009
Zhao et al. 2003
CerebellumPonti et al. 2008a
Brain stemBauer et al. 2005
Bauer et al. 2005
Open in a separate windowUnshaded rows, spontaneous (constitutive) neurogenesis; shaded rows, experimentally induced neurogenesis (growth factor infusion, lesion, etc.). No functional integration has been shown to occur in any of the studies reported here.aNeuronal differentiation of newborn cells has been well documented; in all other cases, neurogenesis has been shown only until the cell-specification step, and/or assessed with less accurate analyses (reslicing not performed, neuronal differentiation not clearly shown, very few cells shown in figures, insufficient or absent quantification).bNeurogenesis reported in this region has been denied by subsequent reports. Only a set of studies are reported; gliogenesis is not considered (data modified from Bonfanti and Peretto 2011).  相似文献   

8.
Signaling by Nuclear Receptors     
Richard Sever  Christopher K. Glass 《Cold Spring Harbor perspectives in biology》2013,5(3)
  相似文献   

9.
Wnt Pathway Regulation of Embryonic Stem Cell Self-Renewal     
Bradley J. Merrill 《Cold Spring Harbor perspectives in biology》2012,4(9)
Embryonic stem cells (ESCs) can generate all of the cell types found in the adult organism. Remarkably, they retain this ability even after many cell divisions in vitro, as long as the culture conditions prevent differentiation of the cells. Wnt signaling and β-catenin have been shown to cause strong effects on ESCs both in terms of stimulating the expansion of stem cells and stimulating differentiation toward lineage committed cell types. The varied effects of Wnt signaling in ESCs, alongside the sometimes unconventional mechanisms underlying the effects, have generated a fair amount of controversy and intrigue regarding the role of Wnt signaling in pluripotent stem cells. Insights into the mechanisms of Wnt function in stem cells can be gained by examination of the causes for seemingly opposing effects of Wnt signaling on self-renewal versus differentiation.For a single-cell embryo to eventually form an adult organism of trillions of cells, some cells in the early mammalian embryo must be able to generate all cell lineages in the animal. The potential to make all adult cell types defines the property of pluripotency, and it is maintained in proliferating cells through a process called self-renewal. As cells become specified to contribute to particular lineages, they typically lose the ability to make cell types from distinct lineages (Waddington 1957; Hochedlinger and Plath 2009). As such, pluripotency is lost during the initial steps of lineage commitment that occur during gastrulation (Beddington 1982, 1983; Lawson and Pedersen 1987; Lawson et al. 1991), which is a process that coordinates the generation of adult cell lineages with the elaboration of a basic three-dimensional body structure (Heisenberg and Solnica-Krezel 2008). In the mouse, pluripotency can be tested with various experiments; the gold standard is the injection of cells into a blastocyst-staged embryo followed by contribution to a diversity of cell types in the chimeric animal or chimeric embryo after gastrulation. Cells are typically considered to have been pluripotent only if they contributed to all three germ layers (endoderm, mesoderm, and ectoderm).Embryonic stem cells (ESCs) are generated in vitro by outgrowths from a preimplantation-staged embryo, frequently a blastocyst. Pluripotent cells from the inner cell mass (ICM) of the blastocyst proliferate to form colonies, which can be expanded into ESC cultures. When culture conditions for in vitro propagation of mouse ESCs (mESCs) were first discovered more than 30 years ago (Evans and Kaufman 1981; Martin 1981), the critical achievement was finding conditions supporting indefinite ESC self-renewal, that is, maintenance of pluripotency following cell division. Compared with the other cell systems discussed below in this article, mESCs ostensibly display the greatest capacity for self-renewal and the highest ability to maintain pluripotency. As such, mESCs are typically thought to represent a primitive, or “naive,” cellular state in the early embryo.Several culture conditions can support self-renewal of mESCs. Initially, ESCs were grown in serum containing media atop a layer of mitotically inactivated fibroblasts, called feeder cells (Evans and Kaufman 1981). Feeder cells secrete the LIF cytokine, which binds a transmembrane receptor complex consisting of LIFR and gp130 proteins (Gearing et al. 1991; Gearing and Bruce 1992; Davis et al. 1993). LIF binding activates Jak/Stat signaling and Stat3 phosphorylation, which promotes ESC self-renewal (Niwa et al. 1998; Matsuda et al. 1999). Convincing proof of LIF’s importance for self-renewal in vitro was shown when recombinant LIF protein was shown to be sufficient to replace feeder cells in ESC cultures (Smith et al. 1988; Williams et al. 1988; Nichols et al. 1990).Essentially the same feeder cells can be used for both mESCs and human ESCs (hESCs); however, discrete activities of the feeders in terms of the cytokines they release are needed to effect optimal self-renewal for each cell. The LIF cytokine important for mESC self-renewal did not stimulate hESC self-renewal (Thomson et al. 1998). Instead, ERK signaling downstream from Fgf2 must accompany a feeder layer in serum-containing media for optimal hESC self-renewal (Xu et al. 2005). Interestingly, recombinant Fgf2 by itself could not replace feeders, and Fgf2 has been suggested to work in part by stimulating feeders to produce Activin/Nodal ligands; the combination of Fgf2 and Nodal/Activin is sufficient to support hESC self-renewal in serum-free chemically defined culture conditions (Vallier et al. 2004, 2009; James et al. 2005).Clear differences exist between mESCs and hESCs. The colonies adopt different morphologies, they require distinct culture conditions for self-renewal, and they have significantly different gene expression signatures (Brons et al. 2007; Tesar et al. 2007). Mouse EpiSCs are made from the epiblast of postimplantation-staged embryos between embryonic days 5.5 (E5.5) and E6.5 of embryogenesis (Brons et al. 2007; Tesar et al. 2007; Han et al. 2010). Lineage specification of pluripotent epiblast cells begins soon after formation of a cup-like structure, and at E6.5, the cells in the epiblast begin to be specified to primary cell lineages during gastrulation. The in vivo cellular environment for ICM cells and postimplantation epiblast cells is considerably different, and it is not surprising that EpiSCs and mESCs display many different characteristics (Xu et al. 2010). However, it was somewhat surprising that EpiSCs share many characteristics with hESCs, including a common colony morphology, Fgf2 + Activin A culture conditions, and gene expression signatures (Brons et al. 2007; Tesar et al. 2007). Like mESCs and hESCs, EpiSCs pass pluripotency tests for in vitro differentiation and teratoma formation. Whereas mESC can efficiently convert (i.e., differentiate) into EpiSC-like cells when switched to Fgf2/Activin A media (Hanna et al. 2009; Greber et al. 2010), EpiSCs required genetic manipulation or reprogramming for efficient conversion to mES-like cells (Guo et al. 2009; Hanna et al. 2009; Greber et al. 2010; Guo and Smith 2010). Many investigators consider hESCs and mouse EpiSCs to be primed for differentiation as they reside in a less primitive differentiation state relative to the naive state of pluripotency in mESCs.

Table 1.

Pluripotent stem cell states: Naive and primed
Mouse ESCHuman ESCMouse EpiSC
Effects of culture conditions
Serum + Lif
Wnt3a/GSK3inhibitor
Fgf2 + Activin A
Self-renewal
Self-renewal
EpiSC
Differentiation
Differentiation
Self-renewal
Differentiation
Differentiation
Self-renewal
Gene expression profiles
Oct4, Sox2, Nanog
Sox17, Eomes, Fgf5
Klf4, Rex1, Stella
High
Low
High
High
High
Low
High
High
Low
Activity in pluripotency tests
Embryoid body
Teratoma formation
Blastocyst injection
Tetraploid complementation
Pass
Pass
Pass
Pass
Pass
Pass
Not determined
Not determined
Pass
Pass
Poor
Not determined
Epigenetic stateNaivePrimedPrimed
Open in a separate windowThree pluripotent cell systems are compared with respect to characteristics that describe their epigenetic state of pluripotency. See text for details.  相似文献   

10.
Wnt/Wingless Signaling in Drosophila     
Sharan Swarup  Esther M. Verheyen 《Cold Spring Harbor perspectives in biology》2012,4(6)
  相似文献   

11.
Functional Characterization of Naturally Occurring Variants of Human Hepatitis B Virus Containing the Core Internal Deletion Mutation     
Thomas Ta-Tung Yuan  Min-Hui Lin  Sui Min Qiu  Chiaho Shih 《Journal of virology》1998,72(3):2168-2176
  相似文献   

12.
Heparan Sulfate Proteoglycans     
Stephane Sarrazin  William C. Lamanna  Jeffrey D. Esko 《Cold Spring Harbor perspectives in biology》2011,3(7)
Heparan sulfate proteoglycans are found at the cell surface and in the extracellular matrix, where they interact with a plethora of ligands. Over the last decade, new insights have emerged regarding the mechanism and biological significance of these interactions. Here, we discuss changing views on the specificity of protein–heparan sulfate binding and the activity of HSPGs as receptors and coreceptors. Although few in number, heparan sulfate proteoglycans have profound effects at the cellular, tissue, and organismal level.Heparan sulfate proteoglycans (HSPGs) are glycoproteins, with the common characteristic of containing one or more covalently attached heparan sulfate (HS) chains, a type of glycosaminoglycan (GAG) (Esko et al. 2009). Cells elaborate a relatively small set of HSPGs (∼17) that fall into three groups according to their location: membrane HSPGs, such as syndecans and glycosylphosphatidylinositol-anchored proteoglycans (glypicans), the secreted extracellular matrix HSPGs (agrin, perlecan, type XVIII collagen), and the secretory vesicle proteoglycan, serglycin (Esko et al. 1985), which allowed functional studies in the context of a cell culture model (Zhang et al. 2006). A decade later, the first HSPG mutants in a model organism (Drosophila melanogaster) were identified (Rogalski et al. 1993; Nakato et al. 1995; Häcker et al. 1997; Bellaiche et al. 1998; Lin et al. 1999), which was followed by identification of mutants in nematodes, tree frogs, zebrafish, and mice (and3).3). HS is evolutionarily ancient and its composition has remained relatively constant from Hydra to humans (Yamada et al. 2007; Lawrence et al. 2008).

Table 1.

Heparan sulfate proteoglycans
ClassProteoglycanCore mass (kDa)aChain type (number)bTissueHuman disease
Membrane-boundSyndecan-1–syndecan-431–45HS (2–3) in Sdc2 and Sdc4; HS/CS (3–4 HS/1-2 CS) in Sdc1 and Sdc3Epithelial cells, fibroblasts
Glypican-1–glypican-657–69HS (1–3)Epithelial cells, fibroblastsSimpson–Golabi–Behmel syndrome (overgrowth) (GPC3) (Pilia et al. 1996); omodysplasia (skeletal dysplasia) (GPC6) (Campos-Xavier et al. 2009)
Betaglycan (part-time PG)110HS/CS (1–2)Fibroblasts
Neuropilin-1 (part-time PG)130HS or CS (1)Endothelial cells
CD44v337HS (1)Lymphocytes
Secretory vesiclesSerglycin10–19Heparin/CS (10–15)Mast cells, hematopoietic cells
Extracellular matrixPerlecan400HS (1–4)Basement membranesSchwartz–Jampel syndrome (skeletal dysplasia) (Nicole 2000; Arikawa-Hirasawa et al. 2001)
Agrin212HS (2–3)Basement membranes
Collagen XVIII150HS (1–3)Epithelial cells, basement membranesKnobloch syndrome type I (Sertie et al. 2000)
Open in a separate windowHS, heparan sulfate; CS, chondroitin sulfate; PG, proteoglycan.aThe variation in core mass is because of species differences.bThe number of chains is based on the number of putative attachment sites for chain initiation as well as data from the literature; the actual number of chains varies by method, tissue, and species.

Table 2.

Mutants altered in HSPG core proteins
GeneProteoglycanPhenotype (references)
Sdc1Syndecan-1Null allele: viable; increase in inflammation-mediated corneal angiogenesis (Gotte et al. 2002, 2005); corneal epithelial cells migrate more slowly, show reduced localization of α9 integrin during wound closure and fail to increase in proliferation after wounding (Stepp et al. 2002); enhanced leukocyte-endothelial interaction in the retina (Gotte et al. 2002, 2005); increase in medial and intimal smooth muscle cell replication and neointimal lesion after injury (Fukai et al. 2009); reduced cardiac fibrosis and dysfunction during angiotensin II–induced hypertension (Schellings et al. 2010); not required for follicle initiation and development (Richardson et al. 2009); accumulates plasma triglycerides, and shows prolonged circulation of injected human VLDL and intestinally derived chylomicrons (Stanford et al. 2009); juvenile mice resistant to carcinogen-induced tumorigenesis (McDermott et al. 2007); increased basal protein leakage and more susceptible to protein loss induced by combinations of IFN-γ, TNF-α, and increased venous pressure (Bode et al. 2008); exacerbates anti-GBM nephritis shifting Th1/Th2 balance toward a Th2 response (Rops et al. 2007); no role in hepatocyte infection by Plasmodium yoelii sporozoites (Bhanot 2002); normal larval development of Trichinella spiralis, but modestly reduced Th2 responses during infection (Beiting et al. 2006); less susceptible to Pseudomonas aeruginosa infection (Haynes et al. 2005); reduced P. aeruginosa infection rate and virulence (Park et al. 2001); protected from Staphylococcus aureus beta-toxin-induced lung injury (Hayashida et al. 2009a); exaggerated airway hyperresponsiveness, eosinophilia, and lung IL-4 responses to allergens (Xu et al. 2005); exaggerated CXC chemokines, neutrophilic inflammation, organ damage, and lethality in LPS endotoxemia (Hayashida et al. 2009b); prolonged recruitment of inflammatory cells in dextran sodium sulfate (DSS)-induced colitis and delayed type hypersensitivity (Masouleh et al. 2009; Floer et al. 2010).
Sdc2Syndecan-2No mutants reported. Sdc2 antisense impairs angiogenesis in human microvascular endothelial cells (Noguer et al. 2009); morpholinos inhibit cell migration and fibrillogenesis during embryogenesis in zebrafish (Arrington and Yost 2009).
Sdc3Syndecan-3Null allele: viable; altered feeding behavior (Strader et al. 2004); no phenotype in synovial endothelial cells (Patterson et al. 2005); enhanced long-term potentiation (LTP) in area CA1 (brain) and impaired performance in tasks assessing hippocampal function (Kaksonen et al. 2002); more sensitive to inhibition of food intake by the melanocortin agonist MTII (Reizes et al. 2003); perturbs laminar structure of the cerebral cortex as a result of impaired radial migration, and neural migration in the rostral migratory stream is impaired (Hienola et al. 2006); novel form of muscular dystrophy characterized by impaired locomotion, fibrosis, and hyperplasia of myonuclei and satellite cells (Cornelison et al. 2004).
Sdc4Syndecan-4Null allele: viable; enhanced fibrin deposition in degenerating fetal vessels in the placental labyrinth (Ishiguro et al. 2000); delayed angiogenesis in wound granulation tissue (Echtermeyer et al. 2001); defective subcellular localization of mTOR Complex2 and Akt activation in endothelial cells, affecting endothelial cell size, NOS, and arterial blood pressure (Partovian et al. 2008); decreased macrophage uptake of phospholipase A2-modified LDL (Boyanovsky et al. 2009); mesangial expansion, enhanced matrix collagens I and IV, fibronectin and focal segmental glomerulosclerosis in males, and induction of Sdc2 in glomeruli (Cevikbas et al. 2008); more susceptible to hepatic injury, and thrombin-cleaved form of osteopontin is significantly elevated after concanavalin-A injection (Kon et al. 2008); less damage in osteoarthritic cartilage in a surgically induced model of osteoarthritis (Echtermeyer et al. 2009); explanted satellite cells fail to reconstitute damaged muscle and are deficient in activation, proliferation, MyoD expression, myotube fusion, and differentiation (Cornelison et al. 2004); vibrissae are shorter and have a smaller diameter because of suboptimal response to fibroblast growth factors (Iwabuchi and Goetinck 2006); lower phosphorylation levels of focal adhesion kinase (Wilcox-Adelman et al. 2002); random migration of fibroblasts as a result of high delocalized Rac1 activity (Bass et al. 2007); defective RGD-independent cell attachment to transglutaminase-fibronectin matrices (Telci et al. 2008); impaired suppression of production of IL-1β by TGF-α (Ishiguro et al. 2002); decreased neutrophil recruitment and increased myofibroblast recruitment and interstitial fibrosis after bleomycin-treatment, no inhibition of fibrosis with recombinant CXCL10 protein (Jiang et al. 2010); hypersensitivity to LPS because of decreased TGF-β suppression of IL-1 production in monocytes and neutrophils (Ishiguro et al. 2001).
Gpc1Glypican-1Null allele: viable; reduced brain size (Jen et al. 2009). Athymic mutant mice show decreased tumor angiogenesis and metastasis (Aikawa et al. 2008).
Gpc2Glypican-2No mutants reported.
Gpc3Glypican-3Null allele: viable; resembles Simpson–Golabi–Behmel overgrowth syndrome, including somatic overgrowth, renal dysplasia, accessory spleens, polydactyly, and placentomegaly (Cano-Gauci et al. 1999; Chiao et al. 2002); defects in cardiac and coronary vascular development (Ng et al. 2009); alterations in Wnt signaling, in vivo inhibition of the noncanonical Wnt/JNK signaling, activation of canonical Wnt/β-catenin signaling (Song et al. 2005); increased Hedgehog signaling (Capurro et al. 2008); abnormal rates of proliferation and apoptosis in cortical and medullary collecting duct cells (Grisaru et al. 2001); delay in endochondral ossification, impairment in the development of the myelomonocytic lineage (Viviano et al. 2005).
Gpc4Glypican-4Zebrafish knypek controls cell polarity during convergent extension (Topczewski et al. 2001); craniofacial skeletal defects in adult fish (LeClair et al. 2009).
Gpc5Glypican-5No mutants reported.
Gpc6Glypican-6Impaired endochondral ossification and omodysplasia (Campos-Xavier et al. 2009).
Tgfbr3BetaglycanNull allele: embryonic lethal; heart and liver defects (Stenvers et al. 2003); defect in seminiferous cord formation in E12.5–13.5 embryos (Sarraj et al. 2010).
Hspg2PerlecanNull allele: embryonic lethal (E10–12); developmental angiogenesis altered in zebrafish (Zoeller et al. 2009); high incidence of malformations of the cardiac outflow tract, lack of well-defined spiral endocardial ridges (Costell et al. 2002); lower amounts of collagen IV and laminins in embryonic hearts, reduced function in infarcted hearts from heterozygous mice (Sasse et al. 2008); absence of acetylcholinesterase at the neuromuscular junctions (Arikawa-Hirasawa et al. 2002); cephalic and skeletal abnormalities (Arikawa-Hirasawa et al. 1999); cerebral ectopias, exencephaly (Girós et al. 2007); increased cross-sectional area of myosin heavy chain type IIb fibers in the tibialis anterior muscle (Xu et al. 2010b); diminished osteocyte canalicular pericellular area (Thompson et al. 2011).
Exon 3 deletion (Hspg23/3) viable: proteinuria after protein loading (Morita et al. 2005); monocyte/macrophage influx impaired in Hspg23/3Col18a1−/– mice in a model of renal ischemia/reperfusion (Celie et al. 2007).
Secreted as CSPG in some tissues (Danielson et al. 1992; Govindraj et al. 2002; Vogl-Willis and Edwards 2004; West et al. 2006), but relationship of CSPG isoform to phenotypes not established.
Prg1SerglycinNull allele: viable; secretory granule defects in mast cells (Abrink et al. 2004); dense core formation is defective in mast cell granules (Henningsson et al. 2006); defective secretory granule maturation and granzyme B storage in cytotoxic T cells (Grujic et al. 2005); no effect on macrophages (Zernichow et al. 2006); platelets and megakaryocytes contain unusual scroll-like membranous inclusions (Woulfe et al. 2008); enlargement of multiple lymphoid organs, decrease in the proportion of CD4+ cells, more pronounced airway inflammatory response in older mice (Wernersson et al. 2009); increased virulence of Klebsiella pneumoniae (Niemann et al. 2007); defective regulation of antiviral CD8+ T-cell responses (Grujic et al. 2008).
AgrnAgrinNull allele: embryonic lethal; reduced number, size, and density of postsynaptic acetylcholine receptor aggregates in muscles; abnormal intramuscular nerve branching and presynaptic differentiation (Gautam et al. 1996,1999); smaller brains (Serpinskaya et al. 1999); abnormal development of interneuronal synapses (Gingras et al. 2007); increased resistance to excitotoxic injury (Hilgenberg et al. 2002); reduced number of cortical presynaptic and postsynaptic specializations (Ksiazek et al. 2007).
Floxed allele: Inactivation in podocytes does not affect glomerular charge selectivity or glomerular architecture (Harvey et al. 2007).
Col18a1Collagen XVIIINull allele: viable; increased microvascular growth (Li and Olsen 2004); increased angiogenesis associated with atherosclerotic plaques (Moulton et al. 2004); delayed regression of blood vessels in the vitreous along the surface of the retina after birth and lack of or abnormal outgrowth of retinal vessels (Fukai et al. 2002); larger choroidal neovascularization lesions and increased vascular leakage (Marneros et al. 2007); accelerated healing and vascularization rate of excisional dorsal skin wounds (Seppinen et al. 2008); anomalous anastomoses of vasculature; disruption of the posterior iris pigment epithelial cell layer with release of melanin granules, severe thickening of the stromal iris basement membrane zone (Marneros and Olsen 2003); increase in the amount of retinal astrocytes (Hurskainen et al. 2005); more severe glomerular and tubulointerstitial injury in induced anti-GBM glomerulonephritis (Hamano et al. 2010); monocyte/macrophage influx impaired in Hspg23/3Col18a1−/– mice in a model of renal ischemia/reperfusion (Celie et al. 2007); mild chylomicronemia (Bishop et al. 2010).
Open in a separate window

Table 3.

Mouse mutants altered in HS biosynthesis
GeneEnzymePhenotype
Xt1Xylosyltransferase-1No mutants reported.
Xt2Xylosyltransferase-2Null allele: viable; polycystic kidney and livers (Condac et al. 2007).
GalTI (β4GalT7)Galactosyltransferase IHuman mutants: defective chondroitin substitution of decorin and biglycan in an Ehlers–Danlos patient (Gotte and Kresse 2005; Seidler et al. 2006).
GalTII (β3GalT6)Galactosyltransferase IINo mutants reported.
Glcat1Glucuronyltransferase INull allele: embryonic lethal (4–8-cell stage) (Izumikawa et al. 2010).
Extl3N-acetylglucosaminyl transferase IFloxed allele: Inactivation in islets decreases growth and insulin secretion (Takahashi et al. 2009).
Ext1/Ext2HS Copolymerase (N-acetylglucosaminyl-glucuronyltransferase)Null allele: embryonic lethal (E6-7.5); lack of mesoderm differentiation (Lin et al. 2000; Stickens et al. 2005); heterozygotes develop rib growth plate exostoses (Stickens et al. 2005; Zak et al. 2011); unaltered vascular permeability in heterozygous mice (Xu et al. 2010a).
Floxed allele of Ext1: defective brain morphogenesis and midline axon guidance after nestin-Cre inactivation (Inatani et al. 2003); no effect on adaptive immune response in CD15Cre mice (Garner et al. 2008); altered T-cell and dendritic cell homing to lymph nodes in Tie2Cre mice (Bao et al. 2010); rib growth plate exostosis formation in Col2Cre mice (Jones et al. 2010; Matsumoto et al. 2010; Zak et al. 2011).
Ndst1N-acetylglucosaminyl N-deacetylase/N-sulfotransferase-1Null allele: Perinatal lethal; lung hypoplasia, defective forebrain, lens, and skull development (Fan et al. 2000; Ringvall et al. 2000; Grobe et al. 2005; Pan et al. 2006).
Floxed allele: decreased chemokine transcytosis and presentation and neutrophil infiltration in Tie2Cre mice (Wang et al. 2005); decreased allergen-induced airway hyperresponsiveness and inflammation because of reduction in recruitment of eosinophils, macrophages, neutrophils, and lymphocytes in Tie2Cre mice (Zuberi et al. 2009); decreased pathological angiogenesis in Tie2Cre mice (Fuster et al. 2007); decreased vascular VEGF-induced hyperpermeability (Xu et al. 2010a); decreased vascular smooth muscle cell proliferation, vessel size, and vascular remodeling after arterial injury in SM22αCre mice (Adhikari et al. 2010a); mild effect on T-cell response in Tie2Cre;Ndst2−/−mice (Garner et al. 2008); defective lacrimal gland development and Fgf10-Fgfr2b complex formation and signaling in LeCre mice (Pan et al. 2008); defective lobuloalveolar development in mammary gland (Crawford et al. 2010).
Ndst2N-acetylglucosaminyl N-deacetylase/N-sulfotransferase-2Null allele: viable; mast cell deficiency and defective storage of proteases (Forsberg et al. 1999; Humphries et al. 1999); compounding mutation with Ndst1 reduces l-selectin interactions (Wang et al. 2005).
Ndst3N-acetylglucosaminyl N-deacetylase/N-sulfotransferase-3Null allele: viable; floxed allele available (Pallerla et al. 2008).
Ndst4N-acetylglucosaminyl N-deacetylase/N-sulfotransferase-4No mutants reported.
GlceUronyl C5 epimeraseNull allele: perinatal lethal; renal agenesis (Li et al. 2003).
H2stUronyl 2-O-sulfotransferaseNull allele: perinatal lethal; renal agenesis; skeletal and ocular defects (Bullock et al. 1998; Merry et al. 2001); defective cerebral cortical development (McLaughlin et al. 2003); altered lacrimal gland development (Qu et al. 2011).
Floxed allele: altered lipoprotein clearance in AlbCre mice (Stanford et al. 2010); altered branching morphogenesis in the mammary gland (Garner et al. 2011).
H3st1Glucosaminyl 3-O-sulfotransferase 1Null allele: partially penetrant lethality; no alteration in coagulation (HajMohammadi et al. 2003); fertility defects because of impaired ovarian function and placenta development (Shworak et al. 2002; HajMohammadi et al. 2003).
H3st2Glucosaminyl 3-O-sulfotransferase 2Null allele; viable; no neuronal phenotype (Hasegawa and Wang 2008).
H3st3Glucosaminyl 3-O-sulfotransferase 3No mutants reported.
H3st4Glucosaminyl 3-O-sulfotransferase 4No mutants reported.
H3st5Glucosaminyl 3-O-sulfotransferase 5No mutants reported.
H3st6Glucosaminyl 3-O-sulfotransferase 6No mutants reported.
H6st1Glucosaminyl 6-O-sulfotransferase 1Null allele: embryonic lethal (Habuchi et al. 2007; Sugaya et al. 2008).
Gene trap allele: embryonic lethal; retinal axon guidance defects (Pratt et al. 2006).
Floxed allele: systemic inactivation embryonic lethal (Izvolsky et al. 2008); no change in plasma triglycerides in AlbCre mice (Stanford et al. 2010).
H6st2Glucosaminyl 6-O-sulfotransferase 2Null allele: viable (Sugaya et al. 2008); HS6ST-2, but not HS6ST-1, morphants in zebrafish show abnormalities in the branching morphogenesis of the caudal vein (Chen et al. 2005).
H6st3Glucosaminyl 6-O-sulfotransferase 3No mutants reported.
HpaHeparanase, transgeneAccelerated wound angiogenesis, enhanced delayed type hypersensitivity response (Zcharia et al. 2005; Edovitsky et al. 2006; Ilan et al. 2006); accumulation of intracellular crystals of protein Ym1 in macrophages (Waern et al. 2010); resistance to amyloid protein A amyloidosis (Li et al. 2005); age-related enlargement of lymphoid tissue and altered leukocyte composition (Wernersson et al. 2009).
HpaHeparanaseNull allele: viable; altered MMP-2 and MMP-14 expression (Zcharia et al. 2009).
Sulf1Endo-6-sulfatase 1Null allele: viable; esophageal defect (Ai et al. 2007; Ratzka et al. 2008); enhanced osteoarthritis, MMP-13, ADAMTS-5, and noggin elevated, col2a1 and aggrecan reduced in cartilage and chondrocytes (Otsuki et al. 2010).
Sulf2Endo-6-sulfatase 2Null allele: viable; behavioral defects (Lamanna et al. 2006); enhanced osteoarthritis, MMP-13, ADAMTS-5, and noggin elevated, col2a1 and aggrecan reduced in cartilage and chondrocytes (Otsuki et al. 2010).
Gene trap allele: Sulf2GT(pGT1TMpfs)155Ska, no phenotype (Lum et al. 2007).
Open in a separate windowFigure 1 shows in pictorial form many of the systems in which HSPGs participate.
  1. HSPGs are present in basement membranes (perlecan, agrin, and collagen XVIII), where they collaborate with other matrix components to define basement membrane structure and to provide a matrix for cell migration.
  2. HSPGs are found in secretory vesicles, most notably serglycin, which plays a role in packaging granular contents, maintaining proteases in an active state, and regulating various biological activities after secretion such as coagulation, host defense, and wound repair.
  3. HSPGs can bind cytokines, chemokines, growth factors, and morphogens, protecting them against proteolysis. These interactions provide a depot of regulatory factors that can be liberated by selective degradation of the HS chains. They also facilitate the formation of morphogen gradients essential for cell specification during development and chemokine gradients involved in leukocyte recruitment and homing.
  4. HSPGs can act as receptors for proteases and protease inhibitors regulating their spatial distribution and activity.
  5. Membrane proteoglycans cooperate with integrins and other cell adhesion receptors to facilitate cell-ECM attachment, cell–cell interactions, and cell motility.
  6. Membrane HSPGs act as coreceptors for various tyrosine kinase-type growth factor receptors, lowering their activation threshold or changing the duration of signaling reactions.
  7. Membrane HSPGs act as endocytic receptors for clearance of bound ligands, which is especially relevant in lipoprotein metabolism in the liver and perhaps in the formation of morphogen gradients during development.
Open in a separate windowFigure 1.HSPGs have multiple activities in cells and tissues. (Adapted from Bishop et al. 2007; reprinted with permission from Nature Publishing Group © 2007.)This article is divided into 10 subsections. The first three are written for investigators outside the field who may need some background information on the diversity of HSPGs and the interactions that occur with protein ligands. The subsequent sections describe seven systems that illustrate general principles or ideas that have undergone a significant shift over the last decade. Because of space limitations not all subjects can be considered or treated in appropriate depth and therefore the reader is referred to excellent recent review articles (Tkachenko et al. 2005; Bulow and Hobert 2006; Bishop et al. 2007; Lamanna et al. 2007; Bix and Iozzo 2008; Filmus et al. 2008; Ori et al. 2008; Rodgers et al. 2008; Sanderson and Yang 2008; Iozzo et al. 2009; Couchman 2010).  相似文献   

13.
Evidence for a New Avian Paramyxovirus Serotype 10 Detected in Rockhopper Penguins from the Falkland Islands     
Patti J. Miller  Claudio L. Afonso  Erica Spackman  Melissa A. Scott  Janice C. Pedersen  Dennis A. Senne  Justin D. Brown  Chad M. Fuller  Marcela M. Uhart  William B. Karesh  Ian H. Brown  Dennis J. Alexander  David E. Swayne 《Journal of virology》2010,84(21):11496-11504
The biological, serological, and genomic characterization of a paramyxovirus recently isolated from rockhopper penguins (Eudyptes chrysocome) suggested that this virus represented a new avian paramyxovirus (APMV) group, APMV10. This penguin virus resembled other APMVs by electron microscopy; however, its viral hemagglutination (HA) activity was not inhibited by antisera against any of the nine defined APMV serotypes. In addition, antiserum generated against this penguin virus did not inhibit the HA of representative viruses of the other APMV serotypes. Sequence data produced using random priming methods revealed a genomic structure typical of APMV. Phylogenetic evaluation of coding regions revealed that amino acid sequences of all six proteins were most closely related to APMV2 and APMV8. The calculation of evolutionary distances among proteins and distances at the nucleotide level confirmed that APMV2, APMV8, and the penguin virus all were sufficiently divergent from each other to be considered different serotypes. We propose that this isolate, named APMV10/penguin/Falkland Islands/324/2007, be the prototype virus for APMV10. Because of the known problems associated with serology, such as antiserum cross-reactivity and one-way immunogenicity, in addition to the reliance on the immune response to a single protein, the hemagglutinin-neuraminidase, as the sole base for viral classification, we suggest the need for new classification guidelines that incorporate genome sequence comparisons.Viruses from the Paramyxoviridae family have caused disease in humans and animals for centuries. Over the last 40 years, many paramyxoviruses isolated from animals and people have been newly described (16, 17, 22, 29, 31, 32, 36, 42, 44, 46, 49, 58, 59, 62-64). Viruses from this family are pleomorphic, enveloped, single-stranded, nonsegmented, negative-sense RNA viruses that demonstrate serological cross-reactivity with other paramyxoviruses related to them (30, 46). The subfamily Paramyxovirinae is divided into five genera: Respirovirus, Morbillivirus, Rubulavirus, Henipavirus, and Avulavirus (30). The Avulavirus genus contains nine distinct avian paramyxovirus (APMV) serotypes (Table (Table1),1), and information on the discovery of each has been reported elsewhere (4, 6, 7, 9, 12, 34, 41, 50, 51, 60, 68).

TABLE 1.

Characteristics of prototype viruses APMV1 to APMV9 and the penguin virus
StrainHostDiseaseDistributionFusion cleavagecGI accession no.
APMV1/Newcastle disease virus>250 speciesHigh mortalityWorldwideGRRQKRF45511218
InapparentWorldwideGGRQGRLa11545722
APMV2/Chicken/CA/Yucaipa/1956Turkey, chickens, psittacines, rails, passerinesDecrease in egg production and respiratory diseaseWorldwideDKPASRF169144527
APMV3/Turkey/WI/1968TurkeyMild respiratory disease and moderate egg decreaseWorldwidePRPSGRLa209484147
APMV3/Parakeet/Netherlands/449/1975Psittacines, passerines, flamingosNeurological, enteric, and respiratory diseaseWorldwideARPRGRLa171472314
APMV4/Duck/Hong Kong/D3/1975Duck, geese, chickensNone knownWorldwideVDIQPRF210076708
APMV5/Budgerigar/Japan/Kunitachi/1974Budgerigars, lorikeetsHigh mortality, enteric diseaseJapan, United Kingdom, AustraliaGKRKKRFa290563909
APMV6/Duck/Hong Kong/199/1977Ducks, geese, turkeysMild respiratory disease and increased mortality in turkeysWorldwidePAPEPRLb15081567
APMV7/Dove/TN/4/1975Pigeons, doves, turkeysMild respiratory disease in turkeysUnited States, England, JapanTLPSSRF224979458
APMV8/Goose/DE/1053/1976Ducks, geeseNone knownUnited States, JapanTYPQTRLa226343050
APMV9/Duck/NY/22/1978DucksNone knownWorldwideRIREGRIa217068693
APMV10/Penguin/Falkland Islands/324/2007Rockhopper penguinsNone KnownFalkland IslandsDKPSQRIa300432141
Open in a separate windowaRequires the addition of an exogenous protease.bProtease requirement depends on the isolate examined.cPutative.Six of these serotypes were classified in the latter half of the 1970s, when the most reliable assay available to classify paramyxoviruses was the hemagglutination inhibition (HI) assay (61). However, there are multiple problems associated with the use of serology, including the inability to classify some APMVs by comparing them to the sera of the nine defined APMVs alone (2, 8). In addition, one-way antigenicity and cross-reactivity between different serotypes have been documented for many years (4, 5, 14, 25, 29, 33, 34, 41, 51, 52, 60). The ability of APMVs, like other viruses, to show antigenic drift as it evolves over time (37, 43, 54) and the wide use and availability of precise molecular methods, such as PCR and genome sequencing, demonstrate the need for a more practical classification system.The genetic diversity of APMVs is still largely unexplored, as hundreds of avian species have never been surveyed for the presence of viruses that do not cause significant signs of disease or are not economically important. The emergence of H5N1 highly pathogenic avian influenza (HPAI) virus as the cause of the largest outbreak of a virulent virus in poultry in the past 100 years has spurred the development of surveillance programs to better understand the ecology of avian influenza (AI) viruses in aquatic birds around the globe, and in some instances it has provided opportunities for observing other viruses in wild bird populations (15, 53). In 2007, as part of a seabird health surveillance program in the Falkland Islands (Islas Malvinas), oral and cloacal swabs and serum were collected from rockhopper penguins (Eudyptes chrysocome) and environmental/fecal swab pools were collected from other seabirds.While AI virus has not yet been isolated from penguins in the sub-Antarctic and Antarctic areas, there have been two reports of serum antibodies positive to H7 and H10 from the Adélie species (11, 40). Rare isolations of APMV1, both virulent (45) and of low virulence (8), have been reported from Antarctic penguins. Sera positive for APMV1 and AMPV2 have also been reported (21, 24, 38, 40, 53). Since 1981, paramyxoviruses have been isolated from king penguins (Aptenodytes patagonicus), royal penguins (Eudyptes schlegeli), and Adélie penguins (Pygoscelis adeliae) from Antarctica and little blue penguins (Eudyptula minor) from Australia that cannot be identified as belonging to APMV1 to -9 and have not yet been classified (8, 11, 38-40). The morphology, biological and genomic characteristics, and antigenic relatedness of an APMV recently isolated from multiple penguin colonies on the Falkland Islands are reported here. Evidence that the virus belongs to a new serotype (APMV10) and a demonstration of the advantages of a whole genome system of analysis based on random sequencing followed by comparison of genetic distances are presented. Only after all APMVs are reported and classified will epidemiological information be known as to how the viruses are moving and spreading as the birds travel and interact with other avian species.  相似文献   

14.
Engineering of a Chimeric RB69 DNA Polymerase Sensitive to Drugs Targeting the Cytomegalovirus Enzyme     
Egor P. Tchesnokov  Aleksandr Obikhod  Raymond F. Schinazi  Matthias G?tte 《The Journal of biological chemistry》2009,284(39):26439-26446
  相似文献   

15.
Membrane Domains Based on Ankyrin and Spectrin Associated with Cell–Cell Interactions     
Vann Bennett  Jane Healy 《Cold Spring Harbor perspectives in biology》2009,1(6)
Nodes of Ranvier and axon initial segments of myelinated nerves, sites of cell–cell contact in early embryos and epithelial cells, and neuromuscular junctions of skeletal muscle all perform physiological functions that depend on clustering of functionally related but structurally diverse ion transporters and cell adhesion molecules within microdomains of the plasma membrane. These specialized cell surface domains appeared at different times in metazoan evolution, involve a variety of cell types, and are populated by distinct membrane-spanning proteins. Nevertheless, recent work has shown that these domains all share on their cytoplasmic surfaces a membrane skeleton comprised of members of the ankyrin and spectrin families. This review will summarize basic features of ankyrins and spectrins, and will discuss emerging evidence that these proteins are key players in a conserved mechanism responsible for assembly and maintenance of physiologically important domains on the surfaces of diverse cells.Spectrins are flexible rods 0.2 microns in length with actin-binding sites at each end (Shotton et al. 1979; Bennett et al. 1982) (Fig. 1A). Spectrins are assembled from α and β subunits, each comprised primarily of multiple copies of a 106-amino acid repeat (Speicher and Marchesi 1984). In addition to the canonical 106-residue repeat, β spectrins also have a carboxy-terminal pleckstrin homology domain (Zhang et al. 1995; Macias et al. 1994) and tandem amino-terminal calponin homology domains (Bañuelos et al. 1998), whereas α spectrins contain an Src homology domain 3 (SH3) site (Musacchio et al. 1992), a calmodulin-binding site (Simonovic et al. 2006), and EF hands (Travé et al. 1995) (Fig. 1A). Spectrin α and β subunits are assembled antiparallel and side-to-side into heterodimers, which in turn are associated head-to-head to form tetramers (Clarke 1971; Shotton et al. 1979; Davis and Bennett 1983) (Fig. 1A). In human erythrocytes, in which spectrin was first characterized (Marchesi and Steers 1968; Clarke 1971), actin oligomers containing 10–14 monomers are each linked to five to six spectrin tetramers by accessory proteins to form a geodesic domelike structure that has been resolved by electron microscopy (Byers and Branton 1985). The principal proteins at the spectrin–actin junction are protein 4.1, adducin, tropomyosin, tropomodulin, and dematin (Bennett and Baines 2001) (Open in a separate windowFigure 1.Domain structure and variants of spectrin and ankyrin proteins. (A) Molecular domains of spectrins: Two α spectrins and five β spectrins are shown. Spectrins are comprised of modular units called spectrin repeats (yellow). Other domains such as the ankyrin binding domain (purple), Src-homology domain 3 (SH3, blue), EF-hand domain (red), and calmodulin-binding domain (green) promote interactions with binding targets important for spectrin function. The pleckstrin homology domain (black) promotes association with the plasma membrane and the actin binding domain (grey) tethers the spectrin-based membrane skeleton to the underlying actin cytoskeleton. (B) The spectrin tetramer, the fundamental unit of the spectrin-based membrane skeleton. The spectrin repeat domains of α and β spectrin associate end-to-end to form heterodimers. Heterodimers associate laterally in an antiparallel fashion to form tetramers. The tetramers can then associate end-to-end to form extended macromolecules that link into a geodesic dome shape directly underneath the plasma membrane. (C) Molecular domains present in canonical ankyrins. The membrane binding domain of ankyrin isoforms (orange) is comprised of 24 ANK repeats. The spectrin binding domain (green-blue) allows ankyrins to coordinate integral membrane proteins to the membrane skeleton. The death domain (pink) is the most highly conserved domain. The regulatory domain (brown) is the most variable region of ankyrins. The regulatory domain interacts intramolecularly with the membrane binding domain to modulate ankyrin’s affinity for other binding partners. All ankyrins and spectrins are subject to alternative splicing, which further increases their functional diversity.

Table 1.

Binding partners of spectrin and ankyrins
Spectrin Binding Partners
AlphaBeta
Transporters/ion channels
EnNaC (sodium)
NHE2 (ammonium)
Membrane anchors
PI lipids
Band 4.1
Ankyrin
EAAT4 (glutamate)
Membrane receptors
NMDA receptor
Signaling
RACK-1
Signaling
HsSH3pb1
Calmodulin
Cytoskeleton/cellular transport
F-actin
Adducin
Dynactin
Ankyrin Binding Partners
Membrane BDSpectrin BDDDREG D
Ion channels:
Anion exchanger
Na+/K+ATPase
Voltage-gated
Na+ channels
Na+/Ca2+ Exchanger
KCNG2/3
Rh antigen
IP3 receptor
Ryanodine receptor
Cell adhesion molecules:
L1-CAMs
CD44
E-cadherin
Dystroglycan
Cellular transport:
Tubulin
Clathrin
SpectrinFasLHsp40
Obscurin
PP2A
Open in a separate windowSpectrin is coupled to the inner surface of the erythrocyte membrane primarily through association with ankyrin, which is in turn linked to the cytoplasmic domains of the anion exchanger (Bennett 1978; Bennett and Stenbuck 1979a,b) and Rh/RhAG ammonium transporter (Nicolas et al. 2003). The spectrin-based membrane skeleton and its connections through ankyrin to membrane-spanning proteins are essential for survival of erythrocytes in the circulation, and mutations in these proteins result in hereditary hemolytic anemia (Bennett and Healy 2008). The ankyrin-binding sites of β spectrins 1–4 are located in the 15th spectrin repeat, which is folded identically to other repeats but has distinct surface-exposed residues (Davis et al. 2008; Ipsaro et al. 2009; Stabach et al. 2009) (Figs. 1A, A,2A).2A). Mammalian β-5 spectrin and its ortholog β-H spectrin in Drosophila and Caenorhabditis elegans are the only β spectrins lacking ankyrin-binding activity (Dubreuil et al. 1990; Thomas et al. 1998; McKeown et al. 1998; Stabach and Morrow 2000).Open in a separate windowFigure 2.Ankyrins and spectrins organize macromolecular complexes in diverse types of specialized membranes. (A) Ankyrin-G forms a complex with β-IV spectrin, neurofascin (a cell adhesion protein), and ion channels (KCNQ2/3 and voltage-gated sodium channel) at axon initial segments in Purkinje neurons. (B) In force buffering costameres of skeletal muscle, ankyrins -B and -G cooperate to target and stabilize key components of the dystroglycoprotein complex. At the membrane, ankyrin-G binds to dystrophin and β-dystroglycan. (C) In cardiomyocyte transverse tubules, ankyrins -B and -G coordinate separate microdomains. Ankyrin-B binds Na+/K+ ATPase, Na+/Ca2+ exchanger (NCX-1), and the inositol triphosphate receptor (IP3R). Ankyrin-G forms a complex with Nav1.5 and spectrin. (D) Ankyrin-G in epithelial lateral membrane assembly. Ankyrin-G binds to E-cadherin, β-2 spectrin, and the Na+/K+ ATPase. Spectrins are connected via F-actin bridges bound to α/γ adducin and tropomodulin.Ankyrin interacts with β spectrins through a ZU5 domain (Mohler et al. 2004a; Kizhatil et al. 2007a; Ipsaro et al. 2009) (Fig. 1B), and with most of its membrane partners through ANK repeats (Bennett and Baines 2001) (Fig. 2C,D). In addition, ankyrins have a highly conserve “death domain” and a carboxy-terminal regulatory domain (see the following discussion). The 24 ANK repeats are stacked in a superhelical array to form a solenoid (Michaely et al. 2002). Interestingly, the ANK repeat stack behaves like a reversible spring when stretched by atomic force microscopy, and may function in mechano-coupling in tissues such as the heart (Lee et al. 2006). ANK repeats are components of many proteins and participate in highly diverse protein interactions (Mosavi et al. 2004) (Fig. 2C). This versatile motif currently is being exploited using designed ANK repeat proteins (DARPins) engineered to interact with specific ligands that can function as substitutes for antibodies (Stumpp and Amstutz 2007; Steiner et al. 2008).Spectrin and ankyrin family members are expressed in most, if not all, animal (metazoan) cells, but are not present in bacteria, plants, or fungi. Spectrins are believed to have evolved from an ancestral α-actinin containing calponin homology domains and two spectrin repeats but not other domains (Thomas et al. 1997; Pascual et al. 1997). Ankyrin repeats are expressed in all phyla, presumably because of a combination of evolutionary relationships and in cases of bacteria and viruses by horizontal gene transfer. However, the spectrin-binding domain of ankyrin is present only in metazoans (Fig 1B). It is possible that evolution of ankyrins and spectrins could have been one of the adaptations required for organization of cells into tissues in multicellular animals.The human spectrin family includes two α subunits and five β subunits, whereas Drosophila and C. elegans have a single α subunit and two β subunits (Bennett and Baines 2001). Vertebrate ankyrins are encoded by three genes: ankyrin-R (ANK1) (the isoform first characterized in erythrocytes and also present in a restricted distribution in brain and muscle), ankyrin-B (ANK2), and ankyrin-G (ANK3). Vertebrate ankyrins evolved from a single gene in early chordates (Cai and Zhang 2006). C. elegans ankyrin is encoded by a single gene termed unc-44 (Otsuka et al. 1995), whereas the Drosophila genome contains two ankyrin genes: ankyrin (Dubreuil and Yu 1994) and ankyrin2 (Bouley et al. 2000).Mammalian ankyrins -B and -G are co-expressed in most cells, although they have distinct functions (Mohler et al. 2002; Abdi et al. 2006). Ankyrins -B and -G are closely related in their ANK repeats, and spectrin-binding domains, but diverge in their carboxy-terminal regulatory domains. Regulatory domains are natively unstructured and extended (Abdi et al. 2006). These flexible domains engage in intramolecular interactions with the membrane-binding and spectrin-binding domains (Hall and Bennett 1987; Davis et al. 1992; Abdi et al. 2006) that modulate protein associations and provide functional diversity between otherwise conserved ankyrins.In addition to the standard versions of ankyrins and spectrin subunits depicted in Figure 1, many variants of these proteins are expressed with the addition and/or deletion of functional domains because of alternative splicing of pre-mRNAs. For example, β spectrins can lack PH domains (Hayes et al. 2000), and giant ankyrins have insertions of up to 2000 residues (Kordeli et al. 1995; Chan et al. 1993; Pielage et al. 2008; Koch et al. 2008), whereas other ankyrins lack either the entire membrane-binding domain (Hoock et al. 1997), or both membrane- and spectrin-binding domains (Zhou et al. 1997). The insertions in 440 kDa ankyrin-B and 480 kDa ankyrin-G (Fig. 1B) have an extended conformation that potentially could have specialized roles in connections between the plasma membrane and cytoskeleton of axons where these giant ankyrins reside (Chan et al. 1993; Kordeli et al. 1995) (Fig. 1B). Interestingly, the inserted sequences in Drosophila giant ankyrins interact with microtubules at the presynaptic neuromuscular junction (Pielage et al. 2008) (see the following section).  相似文献   

16.
Immunomodulation by Mesenchymal Stem Cells in Veterinary Species     
Danielle D Carrade  Dori L Borjesson 《Comparative medicine》2013,63(3):207-217
Mesenchymal stem cells (MSC) are adult-derived multipotent stem cells that have been derived from almost every tissue. They are classically defined as spindle-shaped, plastic-adherent cells capable of adipogenic, chondrogenic, and osteogenic differentiation. This capacity for trilineage differentiation has been the foundation for research into the use of MSC to regenerate damaged tissues. Recent studies have shown that MSC interact with cells of the immune system and modulate their function. Although many of the details underlying the mechanisms by which MSC modulate the immune system have been defined for human and rodent (mouse and rat) MSC, much less is known about MSC from other veterinary species. This knowledge gap is particularly important because the clinical use of MSC in veterinary medicine is increasing and far exceeds the use of MSC in human medicine. It is crucial to determine how MSC modulate the immune system for each animal species as well as for MSC derived from any given tissue source. A comparative approach provides a unique translational opportunity to bring novel cell-based therapies to the veterinary market as well as enhance the utility of animal models for human disorders. The current review covers what is currently known about MSC and their immunomodulatory functions in veterinary species, excluding laboratory rodents.Abbreviations: AT, adipose tissue; BM, Bone marrow; CB, umbilical cord blood; CT, umbilical cord tissue; DC, dendritic cell; IDO, indoleamine 2;3-dioxygenase; MSC, mesenchymal stem cells; PGE2, prostaglandin E2; VEGF, vascular endothelial growth factorMesenchymal stem cells (MSC, alternatively known as mesenchymal stromal cells) were first reported in the literature in 1968.39 MSC are thought to be of pericyte origin (cells that line the vasculature)21,22 and typically are isolated from highly vascular tissues. In humans and mice, MSC have been isolated from fat, placental tissues (placenta, Wharton jelly, umbilical cord, umbilical cord blood), hair follicles, tendon, synovial membrane, periodontal ligament, and every major organ (brain, spleen, liver, kidney, lung, bone marrow, muscle, thymus, pancreas, skin).23,121 For most current clinical applications, MSC are isolated from adipose tissue (AT), bone marrow (BM), umbilical cord blood (CB), and umbilical cord tissue (CT; 11,87,99 Clinical trials in human medicine focus on the use of MSC both for their antiinflammatory properties (graft-versus-host disease, irritable bowel syndrome) and their ability to aid in tissue and bone regeneration in combination with growth factors and bone scaffolds (clinicaltrials.gov).131 For tissue regeneration, the abilities of MSC to differentiate and to secrete mediators and interact with cells of the immune system likely contribute to tissue healing (Figure 1). The current review will not address the specific use of MSC for orthopedic applications and tissue regeneration, although the topic is covered widely in current literature for both human and veterinary medicine.57,62,90

Table 1.

Tissues from which MSC have been isolated
Tissue source (reference no.)
SpeciesFatBone marrowCord bloodCord tissueOther
Cat1348356
Chicken63
Cow13812108
Dog973, 5978, 119139Periodontal ligament65
Goat66964
Horse26, 13037, 40, 12367130Periodontal ligament and gingiva88
Nonhuman primate28, 545
Pig1351147014, 20, 91
Rabbit1288032Fetal liver93
Sheep849542, 55
Open in a separate windowOpen in a separate windowFigure 1.The dual roles of MSC: differentiation and modulation of inflammation.Long-term studies in veterinary species have shown no adverse effects with the administration of MSC in a large number of animals.9,10,53 Smaller, controlled studies on veterinary species have shown few adverse effects, such as minor localized inflammation after MSC administration in vivo.7,15,17,45,86,92,98 Private companies, educational institutions, and private veterinary clinics (including Tufts University, Cummins School of Veterinary Medicine, University of California Davis School of Veterinary Medicine, VetStem, Celavet, Alamo Pintado Equine Medical Center, and Rood and Riddle Equine Hospital) offer MSC as a clinical treatment for veterinary species. Clinical uses include tendon and cartilage injuries, tendonitis, and osteoarthritis and, to a lesser extent, bone regeneration, spinal cord injuries, and liver disease in both large and small animals.38,41,113 Even with this broad clinical use, there have been no reports of severe adverse effects secondary to MSC administration in veterinary patients.  相似文献   

17.
Comparative Analysis of Myxococcus Predation on Soil Bacteria     
Andrew D. Morgan  R. Craig MacLean  Kristina L. Hillesland  Gregory J. Velicer 《Applied and environmental microbiology》2010,76(20):6920-6927
Predator-prey relationships among prokaryotes have received little attention but are likely to be important determinants of the composition, structure, and dynamics of microbial communities. Many species of the soil-dwelling myxobacteria are predators of other microbes, but their predation range is poorly characterized. To better understand the predatory capabilities of myxobacteria in nature, we analyzed the predation performance of numerous Myxococcus isolates across 12 diverse species of bacteria. All predator isolates could utilize most potential prey species to effectively fuel colony expansion, although one species hindered predator swarming relative to a control treatment with no growth substrate. Predator strains varied significantly in their relative performance across prey types, but most variation in predatory performance was determined by prey type, with Gram-negative prey species supporting more Myxococcus growth than Gram-positive species. There was evidence for specialized predator performance in some predator-prey combinations. Such specialization may reduce resource competition among sympatric strains in natural habitats. The broad prey range of the Myxococcus genus coupled with its ubiquity in the soil suggests that myxobacteria are likely to have very important ecological and evolutionary effects on many species of soil prokaryotes.Predation plays a major role in shaping both the ecology and evolution of biological communities. The population and evolutionary dynamics of predators and their prey are often tightly coupled and can greatly influence the dynamics of other organisms as well (1). Predation has been invoked as a major cause of diversity in ecosystems (11, 12). For example, predators may mediate coexistence between superior and inferior competitors (2, 13), and differential trajectories of predator-prey coevolution can lead to divergence between separate populations (70).Predation has been investigated extensively in higher organisms but relatively little among prokaryotes. Predation between prokaryotes is one of the most ancient forms of predation (27), and it has been proposed that this process may have been the origin of eukaryotic cells (16). Prokaryotes are key players in primary biomass production (44) and global nutrient cycling (22), and predation of some prokaryotes by others is likely to significantly affect these processes. Most studies of predatory prokaryotes have focused on Bdellovibrionaceae species (e.g., see references 51, 55, and 67). These small deltaproteobacteria prey on other Gram-negative cells, using flagella to swim rapidly until they collide with a prey cell. After collision, the predator cells then enter the periplasmic space of the prey cell, consume the host cell from within, elongate, and divide into new cells that are released upon host cell lysis (41). Although often described as predatory, the Bdellovibrionaceae may also be considered to be parasitic, as they typically depend (apart from host-independent strains that have been observed [60]) on the infection and death of their host for their reproduction (47).In this study, we examined predation among the myxobacteria, which are also deltaproteobacteria but constitute a monophyletic clade divergent from the Bdellovibrionaceae (17). Myxobacteria are found in most terrestrial soils and in many aquatic environments as well (17, 53, 74). Many myxobacteria, including the model species Myxococcus xanthus, exhibit several complex social traits, including fruiting body formation and spore formation (14, 18, 34, 62, 71), cooperative swarming with two motility systems (64, 87), and group (or “wolf pack”) predation on both bacteria and fungi (4, 5, 8, 9, 15, 50). Using representatives of the genus Myxococcus, we tested for both intra- and interspecific variation in myxobacterial predatory performance across a broad range of prey types. Moreover, we examined whether prey vary substantially in the degree to which they support predatory growth by the myxobacteria and whether patterns of variation in predator performance are constant or variable across prey environments. The latter outcome may reflect adaptive specialization and help to maintain diversity in natural populations (57, 59).Although closely related to the Bdellovibrionaceae (both are deltaproteobacteria), myxobacteria employ a highly divergent mode of predation. Myxobacteria use gliding motility (64) to search the soil matrix for prey and produce a wide range of antibiotics and lytic compounds that kill and decompose prey cells and break down complex polymers, thereby releasing substrates for growth (66). Myxobacterial predation is cooperative both in its “searching” component (6, 31, 82; for details on cooperative swarming, see reference 64) and in its “handling” component (10, 29, 31, 32), in which secreted enzymes turn prey cells into consumable growth substrates (56, 83). There is evidence that M. xanthus employs chemotaxis-like genes in its attack on prey cells (5) and that predation is stimulated by close contact with prey cells (48).Recent studies have revealed great genetic and phenotypic diversity within natural populations of M. xanthus, on both global (79) and local (down to centimeter) scales (78). Phenotypic diversity includes variation in social compatibility (24, 81), the density and nutrient thresholds triggering development (33, 38), developmental timing (38), motility rates and patterns (80), and secondary metabolite production (40). Although natural populations are spatially structured and both genetic diversity and population differentiation decrease with spatial scale (79), substantial genetic diversity is present even among centimeter-scale isolates (78). No study has yet systematically investigated quantitative natural variation in myxobacterial predation phenotypes across a large number of predator genotypes.Given the previous discovery of large variation in all examined phenotypes, even among genetically extremely similar strains, we anticipated extensive predatory variation as well. Using a phylogenetically broad range of prey, we compared and contrasted the predatory performance of 16 natural M. xanthus isolates, sampled from global to local scales, as well as the commonly studied laboratory reference strain DK1622 and representatives of three additional Myxococcus species: M. flavescens (86), M. macrosporus (42), and M. virescens (63) (Table (Table1).1). In particular, we measured myxobacterial swarm expansion rates on prey lawns spread on buffered agar (31, 50) and on control plates with no nutrients or with prehydrolyzed growth substrate.

TABLE 1.

List of myxobacteria used, with geographical origin
Organism abbreviation used in textSpeciesStrainGeographic originReference(s)
A9Myxococcus xanthusA9Tübingen, Germany78
A23Myxococcus xanthusA23Tübingen, Germany78
A30Myxococcus xanthusA30Tübingen, Germany78
A41Myxococcus xanthusA41Tübingen, Germany78
A46Myxococcus xanthusA46Tübingen, Germany78
A47Myxococcus xanthusA47Tübingen, Germany78
A75Myxococcus xanthusA75Tübingen, Germany78
A85Myxococcus xanthusA85Tübingen, Germany78
TVMyxococcus xanthusTvärminneTvärminne, Finland79
PAKMyxococcus xanthusPaklenicaPaklenica, Croatia79
MADMyxococcus xanthusMadeira 1Madeira, Portugal79
WARMyxococcus xanthusWarwick 1Warwick, UK79
TORMyxococcus xanthusToronto 1Toronto, Ontario, Canada79
SUL2Myxococcus xanthusSulawesi 2Sulawesi, Indonesia79
KALMyxococcus xanthusKalalauKalalau, HI79
DAVMyxococcus xanthusDavis 1ADavis, CA79
GJV1Myxococcus xanthusGJV 1Unknown35, 72
MXFL1Myxococcus flavescensMx fl1Unknown65
MXV2Myxococcus virescensMx v2Unknown65
CCM8Myxococcus macrosporusCc m8Unknown65
Open in a separate window  相似文献   

18.
Kv5, Kv6, Kv8, and Kv9 subunits: No simple silent bystanders     
Elke Bocksteins 《The Journal of general physiology》2016,147(2):105-125
  相似文献   

19.
DNA Repair at Telomeres: Keeping the Ends Intact     
Christopher J. Webb  Yun Wu  Virginia A. Zakian 《Cold Spring Harbor perspectives in biology》2013,5(6)
  相似文献   

20.
Multiple roles for cytokinin receptors and cross-talk of signaling pathways     
Teodoro Coba de la Pe?a  Claudia B Cárcamo  M Mercedes Lucas  José J Pueyo 《Plant signaling & behavior》2008,3(10):791-794
  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号